Involvement of hypoxia-inducible factor 1 in human cancer

Internal Medicine

Volumn 41, Issue 2, 2002, Pages 79-83

  Semenza, Gregg L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Angiogenesis; Glycolysis; Immunohistochemistry; Oxygen

Indexed keywords

GENE PRODUCT; GLUCOSE TRANSPORTER; GLYCOLYTIC ENZYME; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PROTEIN SUBUNIT; VASCULOTROPIN;

ADAPTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER MORTALITY; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; ONCOGENE; TRANSCRIPTION REGULATION; TUMOR BIOPSY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 0036122242     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.79     Document Type: Article

References (45)

1. Tumor angiogenesis: Therapeutic implications
2. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
3. Tumor angiogenesis and prognosis
4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
5. Angiogenesis and tumor metastasis
6. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
7. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
8. Causes and effects of heterogeneous perfusion in tumors
9. Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology
10. Stabilization of wild-type p53 by hypoxia-inducible factor 1α
11. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
12. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
13. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis
14. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
15. Suppression of tumor growth through disruption of hypoxia-inducible transcription
16. Hypoxia-inducible factor 1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
17. HIF-1α is required for solid tumor formation and embryonic vascularization
18. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
19. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells
20. The expression and distribution of the hypoxia-inducible transcription factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
21. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
22. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy
23. Levels of hypoxia-inducible factor-1α during breast carcinogenesis
24. Coexpression of hypoxia-inducible factor 1α and vascular endothelial growth factor in Wilms' tumor
25. Expression of hypoxia-inducible factor 1α in brain tumors: Association with angiogenesis, invasion, and progression
26. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
27. Hypoxia inducible factor (HIF-1α and HIF2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy
28. Expression of hypoxia-inducible factor-1α: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
29. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer
30. 2-dependent degradation domain via the ubiquitin-proteasome pathway
31. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
32. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: Its stabilization by hypoxia depends upon redox-induced changes
33. HIF-1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
34. Hypoxia-inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
35. Activation of HIF-1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
36. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
37. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
38. 2 sensing
39. 2-regulated prolyl hydroxylation
40. Reciprocal postive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
41. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
42. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/ FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
43. Loss of PTEN facilitates HIF-1-mediated gene expression
44. ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1α (HIF-1α) and inhibits HIF-1-mediated transcription
45. Hypoxia inducible factor 1: A molecular target for development of novel cancer therapeutics